Beone Medicines

We track 2 ClinicalTrials.gov studies led by Beone Medicines. The portfolio skews toward Phase 3 (1 trials).

2 clinical trials sponsored by Beone Medicines.

Pipeline by Phase

PhaseTrialsDistribution
Phase 3 1
50%
Phase 1 1
50%

Trial Status Breakdown

Trials by Beone Medicines

An Open-Label, Randomized, Multicenter Phase 3 Study Investigating the Efficacy and Safety of BGB-43395 Plus Letrozole Versus CDK4/6 Inhibitors (Abemaciclib, Palbociclib, Ribociclib) Plus Letrozole in Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Systemic Anticancer Treatment for Advanced or Metastatic Disease

NCT07492641 · NOT YET RECRUITING · Phase 3

Phase 1a/1b, Open-Label Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of a CDAC Degrading EGFR, BG-60366, in Patients With EGFR-Mutant Non-Small Cell Lung Cancer

NCT06685718 · ACTIVE NOT RECRUITING · Phase 1

Frequently Asked Questions

How many clinical trials does Beone Medicines sponsor?

Beone Medicines currently sponsors 2 clinical trials tracked on ReadTheTrial. These span Phase 3, Phase 1.

What conditions does Beone Medicines research?

Beone Medicines conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Beone Medicines recruiting for clinical trials?

Check the trial listings below for current recruitment status. Trial recruitment status can change frequently.

Explore More